Additional file 4: of A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial

Abstract

Table S3 provides the baseline characteristics of the per-protocol population. Data are displayed as mean ± SD in the upper row, median (25% percentile – 75% percentile) in the lower row. Categorical variables are displayed as absolute numbers or percentage as indicated. (TIFF 185 kb